Oral administration of: Lentinus edodes β-glucans ameliorates DSS-induced ulcerative colitis in mice via MAPK-Elk-1 and MAPK-PPARγ pathways

Food and Function

Volumn 7, Issue 11, 2016, Pages 4614-4627

  Shi, Limin ^a   Lin, Qinlu ^a   Yang, Tao ^a   Nie, Ying ^a   Li, Xinhua ^b   Liu, Bo ^a   Shen, Junjun ^a   Liang, Ying ^a   Tang, Yiping ^a   Luo, Feijun ^a  

^a CENTRAL SOUTH UNIVERSITY OF FORESTRY AND TECHNOLOGY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASES; HISTOLOGY; IMMUNOLOGY; MOLECULAR INTERACTIONS; NITRIC OXIDE; PHOSPHORYLATION; POLYSACCHARIDES; SODIUM SULFATE; TISSUE;

ANTI-INFLAMMATORY EFFECTS; DEXTRAN SULFATE SODIUM; HISTOPATHOLOGICAL ANALYSIS; INFLAMMATORY CELLS; MITOGEN ACTIVATED PROTEIN KINASE; MOLECULAR MECHANISM; ORAL ADMINISTRATION; ULCERATIVE COLITIS;

MAMMALS;

BETA GLUCAN; DEXTRAN SULFATE; ELK1 PROTEIN, MOUSE; MALONALDEHYDE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; NITRIC OXIDE; PEROXIDASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRANSCRIPTION FACTOR ELK 1;

ANIMAL; CHEMICALLY INDUCED; CHEMISTRY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; INSTITUTE FOR CANCER RESEARCH MOUSE; LENTINULA EDODES; MALE; METABOLISM; MOUSE; ORAL DRUG ADMINISTRATION; RANDOMIZATION; ULCERATIVE COLITIS;

ADMINISTRATION, ORAL; ANIMALS; BETA-GLUCANS; COLITIS, ULCERATIVE; DEXTRAN SULFATE; ETS-DOMAIN PROTEIN ELK-1; GENE EXPRESSION REGULATION; MALE; MALONDIALDEHYDE; MICE; MICE, INBRED ICR; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; NITRIC OXIDE; PEROXIDASE; PPAR GAMMA; RANDOM ALLOCATION; SHIITAKE MUSHROOMS;

EID: 84994890207     PISSN: 20426496     EISSN: 2042650X     Source Type: Journal    
DOI: 10.1039/c6fo01043a     Document Type: Article

References (68)

1. M. Philip D. A. Rowley H. Schreiber Inflammation as a tumor promoter in cancer induction Semin. Cancer Biol. 2004 14 433 439
2. V. Khare K. Dammann M. Asboth et al., Overexpression of PAK1 promotes cell survival in inflammatory bowel diseases and colitis-associated cancer Inflammatory Bowel Dis. 2015 21 2 287 296
3. D. C. Baumgart W. J. Sandborn Inflammatory bowel disease: clinical aspects and established and evolving therapies Lancet 2007 369 1641 1657
4. G. Bouma W. Strober The immunological and genetic basis of inflammatory bowel disease Nat. Rev. Immunol. 2003 3 521 533
5. S. O. Abarikwu Kolaviron, a natural flavonoid from the seeds of Garcinia kola, reduces LPS-induced inflammation in macrophages by combined inhibition of IL-6 secretion, and inflammatory transcription factors, ERK1/2, NF-kappaB, p38, Akt, p-c-JUN and JNK Biochim. Biophys. Acta 2014 1840 2373 2381
6. D. B. Reddy P. Reddanna Chebulagic acid (CA) attenuates LPS-induced inflammation by suppressing NF-kappaB and MAPK activation in RAW264.7 macrophages Biochem. Biophys. Res. Commun. 2009 381 112 117
7. M. A. McGuckin R. Eri L. A. Simms et al., Intestinal barrier dysfunction in inflammatory bowel diseases Inflammatory Bowel Dis. 2009 15 1 100 113
8. L. Daigang Q. Jining L. Jinlai et al., LPS-stimulated inflammation inhibits BMP-9-induced osteoblastic differentiation through crosstalk between BMP/MAPK and Smad signaling Exp. Cell Res. 2016 341 1 54 60
9. L. Tao Y. Qiu X. Fu et al., Angiotensin-converting enzyme 2 activator diminazene aceturate prevents lipopolysaccharide-induced inflammation by inhibiting MAPK and NF-κB pathways in human retinal pigment epithelium J. Neuroinflammation 2016 13 1 13 35
10. I. Okayasu S. Hatakeyama M. Yamada et al., A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice Gastroenterology 1990 98 694 702
11. B. Chassaing J. D. Aitken M. Malleshappa et al., Dextran sulfate sodium (DSS)-induced colitis in mice Curr. Protoc. Immunol. 2014 104 15 25
12. B. Liu Q. Lin T. Yang et al., Oat β-glucan ameliorates dextran sulfate sodium (DSS)-induced ulcerative colitis in mice Food Funct. 2015 6 11 3454 3463
13. C. B. Ahn W. K. Jung S. J. Park et al., Gallic Acid-g-chitosan modulates inflammatory responses in LPS-Stimulated RAW264.7 cells via NF-κB, AP-1 and MAPK pathways Inflammation 2016 39 1 366 374
14. Y. He Y. Yue X. Zheng et al., Curcumin, inflammation, and chronic diseases: how are they linked? Molecules 2015 20 5 9183 9213
15. O. Rop J. Mlcek T. Jurikova Beta-glucans in higher fungi and their health effects Nutr. Rev. 2009 67 11 624 631
16. P. Manzi L. Pizzoferrato Beta-glucans in edible mushrooms Food Chem. 2000 68 315 318
17. K. Shimizu R. Fujita R. Kondo et al., Morphological features and dietary functional components in fruit bodies of two strains of Pholiota adiposa grown on artificial beds J. Wood Sci. 2003 49 2 193 196
18. K. Ishibashi N. N. Miura Y. Adachi et al., Relationship between solubility of grifolan, a fungal 1,3-beta-Dglucan, and production of tumor necrosis factor by macrophages in vitro Biosci., Biotechnol., Biochem. 2001 65 9 1993 2000
19. P. Kalač A review of chemical composition and nutritional value of wild-growing and cultivated mushrooms J. Sci. Food Agric. 2013 93 2 209 218
20. M. Kozarski A. Klaus D. Jakovljevic et al., Antioxidants of edible mushrooms Molecules 2015 20 10 19489 19525
21. S. Patel A. Goyal Recent developments in mushrooms as anti-cancer therapeutics: a review 3 Biotech. 2012 2 1 01 15
22. J. L. Johnson M. B. Jones B. A. Cobb Bacterial capsular polysaccharide prevents the onset of asthma through T-cell activation Glycobiology 2015 25 4 368 375
23. Y. Chen L. Zeng W. Xiong et al., Anti-duck virus hepatitis mechanisms of Bush Sophora Root polysaccharide and its sulfate verified by intervention experiments Virus Res. 2015 204 58 67
24. K. X. Zhu S. P. Nie C. Li et al., Ganoderma atrum polysaccharide improves aortic relaxation in diabetic rats via PI3 K/Akt pathway Carbohydr. Polym. 2014 103 15 520 527
25. W. Chanput M. Reitsma L. Kleinjans et al., β-Glucans are involved in immune-modulation of THP-1 macrophages Mol. Nutr. Food Res. 2012 56 5 822 833
26. B. Djordjevic S. Skugor S. M. Jørgensen et al., Modulation of splenic immune responses to bacterial lipopolysaccharide in rainbow trout (Oncorhynchus mykiss) fed lentinan, a beta-glucan from mushroom Lentinula edodes Fish Shellfish Immunol. 2009 26 2 201 209
27. H. S. Cooper S. N. Murthy R. S. Shah et al., Clinicopathologic study of dextran sulfate sodium experimental murine colitis Lab. Invest. 1993 69 2 238 249
28. H. Inoue I. Arai S. Shibata et al., NG-nitro-L-arginine methyl ester attenuates the maintenance and expression of methamphetamine-induced behavioral sensitization and enhancement of striatal dopamine release J. Pharmacol. Exp. Ther. 1996 277 3 1424 1430
29. M. B. Aldrich E. M. Sevick-Muraca Cytokines are systemic effectors of lymphatic function in acute inflammation Cytokine 2013 64 1 362 369
30. M. Murano K. Maemura I. Hirata et al., Therapeutic effect of intracolonically administered nuclear factor kappa B (p65) antisense oligonucleotide on mouse dextran sulphate sodium (DSS)-induced colitis Clin. Exp. Immunol. 2000 120 1 51 58
31. D. S. Straus C. K. Glass Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms Trends Immunol. 2007 28 12 551 558
32. S. C. Ng C. N. Bernstein M. H. Vatn et al., Geographical variability and environmental risk factors in inflammatory bowel disease Gut 2013 62 4 630 649
33. P. L. Kozuch S. B. Hanauer Treatment of inflammatory bowel disease: a review of medical therapy World J. Gastroenterol. 2008 14 3 354 377
34. D. Burger S. Travis Conventional medical management of inflammatory bowel disease Gastroenterology 2011 140 6 1827 1837
35. R. V. Bryant O. Brain S. P. Travis Conventional drug therapy for inflammatory bowel disease Scand. J. Gastroenterol. 2015 50 1 090 112
36. D. C. Baumgart S. R. Carding Inflammatory bowel disease: cause and immunobiology Lancet 2007 369 9573 1627 1640
37. W. Strober I. J. Fuss Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases Gastroenterology 2011 140 6 1756 1767
38. I. Vietor P. Schwenger W. Li et al., Tumor necrosis factor-induced activation and increased tyrosine phosphorylation of mitogen-activated protein (MAP) kinase in human fibroblasts J. Biol. Chem. 1993 268 25 18994 18999
39. L. X. Sang B. Chang C. Dai et al., Heat-killed VSL#3 ameliorates dextran sulfate sodium (DSS)-induced acute experimental colitis in rats Int. J. Mol. Sci. 2013 15 1 15 28
40. C. J. March B. Mosley A. Larsen et al., Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs Nature 1985 315 6021 641 647
41. M. Cappello S. Keshav C. Prince et al., Detection of mRNAs for macrophage products in inflammatory bowel disease by in situ hybridisation Gut 1992 33 9 1214 1219
42. Y. Li C. Yu W. M. Zhu et al., Triptolide ameliorates IL-10-deficient mice colitis by mechanisms involving suppression of IL-6/STAT3 signaling pathway and down-regulation of IL-17 Mol. Immunol. 2010 47 15 2467 2474
43. J. H. Hwang K. J. Kim S. J. Ryu et al., Caffeine prevents LPS-induced inflammatory responses in RAW264.7 cells and zebrafish Chem.-Biol. Interact. 2016 248 1 7
44. J. Zheng J. Wu J. Chen et al., Therapeutic effects of quercetin on early inflammation in hypertriglyceridemia-related acute pancreatitis and its mechanism Pancreatology 2016 16 2 200 210
45. F. Saijo A. B. Milsom N. S. Bryan et al., On the dynamics of nitrite, nitrate and other biomarkers of nitric oxide production in inflammatory bowel disease Nitric Oxide 2010 22 2 155 167
46. D. Conze T. Krahl N. Kennedy et al., c-Jun NH (2)-terminal kinase (JNK)1 and JNK2 have distinct roles in CD8(+) T cell activation J. Exp. Med. 2002 195 811 823
47. Y. Wang Q. Tu W. Yan et al., CXC195 suppresses proliferation and inflammatory response in LPS-induced human hepatocellular carcinoma cells via regulating TLR4-MyD88-TAK1-mediated NF-κB and MAPK pathway Biochem. Biophys. Res. Commun. 2015 456 1 373 379
48. J. M. Kyriakis J. Avruch Mammalian MAPK signal transduction pathways activated by stress and inflammation: a 10-year update Physiol. Rev. 2012 92 2 689 737
49. R. Marais J. Wynne R. Treisman The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain Cell 1993 73 2 381 393
50. J. S. Yordy R. C. Muise-Helmericks Signal transduction and the Ets family of transcription factors Oncogene 2000 19 55 6503 6513
51. M. Cavigelli F. Dolfi F. X. Claret et al., Karin M. Induction of c-fos expression through JNK-mediated TCF/Elk-1 phosphorylation EMBO J. 1995 14 23 5957 5964
52. M. Tresini A. Lorenzini L. Frisoni et al., Lack of Elk-1 phosphorylation and dysregulation of the extracellular regulated kinase signaling pathway in senescent human fibroblast Exp. Cell Res. 2001 269 2 287 300
53. S. Goetze U. Kintscher K. Kaneshiro et al., TNFalpha induces expression of transcription factors c-fos, Egr-1, and Ets-1 in vascular lesions through extracellular signal-regulated kinases 1/2 Atherosclerosis 2001 159 1 93 101
54. S. H. Liu L. T. Lee N. Y. Hu et al., Effects of alpha-mangostin on the expression of anti-inflammatory genes in U937 cells China's Med. 2012 7 1 19 31
55. M. Guma G. S. Firestein c-Jun N-terminal kinase in inflammation and rheumatic diseases Open Rheumatol. J. 2012 6 220 231
56. Z. Q. Wang D. C. Wu F. P. Huang et al., Inhibition of MEK/ERK 1/2 pathway reduces pro-inflammatory cytokine interleukin-1 expression in focal cerebral ischemia Brain Res. 2004 996 1 55 66
57. C. Dreyer G. Krey H. Keller et al., Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors Cell 1992 68 5 879 887
58. E. Hu J. B. Kim P. Sarraf et al., Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma Science 1996 274 5295 2100 2103
59. N. Marx B. Kehrle K. Kohlhammer et al., PPAR activators as antiinflammatory mediators in human T lymphocytes: implications for atherosclerosis and transplantation associated arteriosclerosis Circ. Res. 2002 90 6 703 710
60. C. Jieun L. Yunna A novel Peroxisome Proliferator-Activated Receptor (PPAR) γ agonist 2-Hydroxyethyl.5-Chloro-4, 5-Didehydrojasmonate exerts anti-inflammatory effects in colitis J. Biol. Chem. 2015 290 42 25609 25619
61. J. D. Alexis N. Wang W. Che et al., Bcr kinase activation by angiotensin II inhibits peroxisome-proliferator-activated receptor gamma transcriptional activity in vascular smooth muscle cells Circ. Res. 2009 104 1 69 78
62. J. T. Huang J. S. Welch M. Ricote et al., Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase Nature 1999 400 6742 378 382
63. M. Li G. Pascual C. K. Glass Peroxisome proliferator-activated receptor gamma-dependent repression of the inducible nitric oxide synthase gene Mol. Cell. Biol. 2000 20 13 4699 4707
64. M. Ricote A. C. Li T. M. Willson et al., The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation Nature 1998 391 6662 79 82
65. A. Malur A. J. Mccoy S. Arce et al., Deletion of PPAR gamma in alveolar macrophages is associated with a Th-1 pulmonary inflammatory response J. Immunol. 2009 182 9 5816 5822
66. E. Rigamonti C. Fontaine B. Lefebvre et al., Induction of CXCR2 receptor by peroxisome proliferator-activated receptor gamma in human macrophages Arterioscler., Thromb., Vasc. Biol. 2008 28 5 932 939
67. T. Zhu W. Zhang S. J. Feng et al., Emodin suppresses LPS-induced inflammation in RAW264.7 cells through a PPARγ-dependent pathway Int. Immunopharmacol. 2016 34 16 24
68. B. M. Necela W. Su E. A. Thompson Toll-like receptor 4 mediates cross-talk between peroxisome proliferator-activated receptor gamma and nuclear factor-kappaB in macrophages Immunology 2008 125 3 344 358